Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. L.C.L.T. (Léon) van Kempen
University Medical Center Groningen

dr. L.C.L.T. (Léon) van Kempen

Klinisch Moleculair Bioloog in de Pathologie
Profielfoto van dr. L.C.L.T. (Léon) van Kempen
Telefoon:
050 361 5129 (Office)
Staff assistant:
050 361 0020 (Mrs. Annet Bouman - Van der Jagt)
E-mail:
l.van.kempen umcg.nl

Research interests

Clinical Scientist in Molecular Pathology, molecular diagnostic service. 

Research interests: Molecular biology and pathology of melanoma and non-small cell lung cancer. 

Publicaties

Corrigendum to "Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands" [Eur J Cancer 205 (2024)114125]

Ferroptosis inhibition protects against α-synuclein-related neuronal cell death

Radiotherapy Response Prediction in Myxofibrosarcomas and Undifferentiated Soft Tissue Sarcomas Using DNA Methylation and Copy Number Profiling

SOX2 Is a Potential Diagnostic Biomarker and Anticancer Target in Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa: A Case Series Study

Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative Study

Classification of Fibro-osseous Tumors in the Craniofacial Bones using DNA Methylation and Copy Number Alterations

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients

Enhancing precision in sarcoma diagnosis: nCounter fusion panel implementation in a middle-income country

Genome-Wide DNA Methylation and Copy Number Alterations in Gastrointestinal Stromal Tumors

Large language model-based approach for low-cost, rapid and accurate automated extraction of predictive biomarker testing results from Dutch pathology reports

Pers/media

NanoString Launches nCounter TCR Diversity Panel and Analysis Package at th

NVVP magazine 2021-01

Moleculaire diagnostiek voor de detectie van RET- en NTRK-fusies bij kanker

Successful Molecular Tumor Board

Effectiveness of the UMCG Molecular Tumor Board

Detectie van fusiegenen: kwaliteitscontrole en nieuwe methodologie

Moleculaire Tumor Boards

cBioportal at HealtRI

Opening of the Molecualr Pathology Centre, Montreal, QC, 2014

Opening of the Molecular Pathology Center, Montreal, QC, Canada, 2014

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 16 – Vrede, rechtvaardigheid en sterke instellingen

Meer informatie over de Sustainable Development Goals.